Xolair 150 MG/ML 1S
Ended Awarded
- Contract number
- SPE2DX25FKVVF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $8,561
Award facts
- Contract value 100% obligated
- $8,561.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $8,561.10 for XOLAIR 150 mg/ml. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion single-award vehicle valid through November 2026. The award carries no set-aside designation and is scheduled for completion by August 19, 2025. XOLAIR is a biologic medication used in the treatment of moderate-to-severe allergic asthma and chronic idiopathic urticaria, and this delivery order fulfills pharmaceutical supply requirements for Department of Defense healthcare facilities.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, leveraging its established relationship with the DLA to distribute a comprehensive range of branded and generic prescription drugs, biologics, vaccines, and medical consumables to military health facilities nationwide. The company's IDC with the DLA enables the agency to issue firm fixed-price delivery orders for various pharmaceutical products supporting medical supply needs across the defense healthcare system. This particular delivery order represents one of numerous pharmaceutical product deliveries the company has secured through its federal contract portfolio, which historically includes medications for oncology, contraception, immunization, and specialized therapeutic applications.
Quick answers
Who was awarded contract SPE2DX25FKVVF?
SPE2DX25FKVVF was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 7, 2025.
How much is contract SPE2DX25FKVVF worth?
The government has obligated $8,561 on SPE2DX25FKVVF.
Is contract SPE2DX25FKVVF an order under another contract?
Yes. SPE2DX25FKVVF is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVVF competed?
The extent of competition for SPE2DX25FKVVF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award